Flutamide withdrawal and concomitant initiation of aminoglutethimide in patients with hormone refractory prostate cancer

Acta Oncol. 1996;35(6):763-5. doi: 10.3109/02841869609084015.

Authors

W D Figg¹, N Dawson, M N Middleman, O Brawley, R M Lush, A Senderowicz, S H Steinberg, A Tompkins, E Reed, O Sartor

Affiliation

¹ Clinical Pharmacology Branch, National Cancer Institute, National Institute of Health, Bethesda, Maryland, USA.

PMID: 8938230
DOI: 10.3109/02841869609084015

No abstract available

MeSH terms

Aged
Aminoglutethimide / administration & dosage*
Androgen Antagonists / administration & dosage*
Antineoplastic Agents, Hormonal / administration & dosage*
Drug Resistance, Neoplasm
Flutamide / administration & dosage*
Humans
Male
Middle Aged
Prostatic Neoplasms / drug therapy*
Prostatic Neoplasms / physiopathology

Substances

Androgen Antagonists
Antineoplastic Agents, Hormonal
Aminoglutethimide
Flutamide